Real‐life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

201637 citationsJournal Articlegreen Open Access

Authors

Mark Hew · Monash University

Andrew Gillman · The Alfred Hospital

Michael Sutherland · Austin Hospital

Peter Wark · John Hunter Hospital

Jeffrey J. Bowden · Flinders Medical Centre

Michael Guo · Woolcock Institute of Medical Research

Helen K. Reddel ·

Abstract

Patients with severe allergic asthma above recommended dosing criteria for omalizumab have significantly improved symptom control, quality of life and lung function to a similar degree to within-range participants, achieved without dose escalation above 750 mg.

Topics & Keywords

Asthma and respiratory diseases Allergic Rhinitis and Sensitization Respiratory and Cough-Related Research

Publication Details

Published in: Clinical & Experimental Allergy

Volume 46, Issue 11, pp. 1407-1415

DOI: 10.1111/cea.12774

Field-Weighted Citation Impact: 3.70

Command Palette

Real‐life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

Authors

Abstract

Topics & Keywords

Publication Details